| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/12/2002 | EP1212362A2 Card proteins involved in cell death regulation |
| 06/12/2002 | EP1212359A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 06/12/2002 | EP1212312A1 Novel derivatives of flavones, xanthones and coumarins |
| 06/12/2002 | EP1212101A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 06/12/2002 | EP1212100A2 Delivery system for antidandruff agent |
| 06/12/2002 | EP1212093A2 Use of emu oil as a carrier for antifungal, antibacterial and antiviral medications |
| 06/12/2002 | EP1212090A2 Pharmaceutical composition comprising an insulin sensitizer |
| 06/12/2002 | EP1212089A2 Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonists |
| 06/12/2002 | EP1212081A2 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure |
| 06/12/2002 | EP1212076A2 Stimulation of sperm function |
| 06/12/2002 | EP1212074A1 Hybrid peptides modulate the immune response |
| 06/12/2002 | EP1212070A1 Plant extract mixtures and their uses |
| 06/12/2002 | EP1212069A2 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 06/12/2002 | EP1212068A1 Method of enhancing the efficacy of anti-tumor agents |
| 06/12/2002 | EP1212067A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 06/12/2002 | EP1212065A1 Compositions and methods for raising hdl cholesterol levels |
| 06/12/2002 | EP1212058A1 Topical treatment for prevention of ocular infections |
| 06/12/2002 | EP1212055A1 Neurotherapeutic composition and method |
| 06/12/2002 | EP1212051A1 Method for treating or preventing chronic prostatitis or chronic pelvic pain syndrome |
| 06/12/2002 | EP1212048A1 Use of sigma receptor agonists for the treatment of depression |
| 06/12/2002 | EP1212041A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 06/12/2002 | EP1212000A1 Method of controlling body temperature while reducing shivering |
| 06/12/2002 | EP1128844A4 Methods for enhancing wound healing |
| 06/12/2002 | EP1044000B1 Combination therapy for the treatment of aids |
| 06/12/2002 | EP1007059A4 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| 06/12/2002 | EP1005337A4 Pharmacologic drug combination in vagal-induced asystole |
| 06/12/2002 | EP0966274B1 Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase |
| 06/12/2002 | EP0876158B1 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms |
| 06/12/2002 | EP0820316B1 Coating for bio-material insertable into the bloodstream or tissue of the human body |
| 06/12/2002 | EP0817864B1 Method for the diagnosis of crohn's disease and ulcerative colitis |
| 06/12/2002 | EP0717625B1 A method of treating liver disease and like indications with vasodilating agents |
| 06/12/2002 | CN1353754A Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF alpha) signaling pathway |
| 06/12/2002 | CN1353706A Integrin receptor ligands |
| 06/12/2002 | CN1353699A Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 06/12/2002 | CN1353616A New use of substance in PNS |
| 06/12/2002 | CN1353614A Method of treating chronic cardiac disease |
| 06/12/2002 | CN1353611A Balsam for treatment of surface burns and chafing rashes |
| 06/12/2002 | CN1353607A Improved pharmaceutical formulations |
| 06/12/2002 | CN1353602A Compositions and methods for treatment of staphylococcal infection |
| 06/12/2002 | CN1353581A Method and composition for masking mineral taste |
| 06/12/2002 | CN1353573A Anti-inflammatory therapy for inflammatory mediated infection |
| 06/12/2002 | CN1353003A Process for screening active component from plant extract |
| 06/12/2002 | CN1352945A Adenosine as anti-thrombosis medicine |
| 06/11/2002 | US6404779 System and method of disharmonic frequency multiplexing |
| 06/11/2002 | US6403764 Variant wherein amino acid residue at position 16 of native-sequence human igf-1 is replaced with glycine or serine, or amino acid residue at position 25 or 49 or residues at 3 and 49 are replaced with alanine, glycine, or serine |
| 06/11/2002 | US6403758 Bioresorbable compositions for implantable prostheses |
| 06/11/2002 | US6403656 Skin disorders |
| 06/11/2002 | US6403647 Pulsed administration of compositions for the treatment of blood disorders |
| 06/11/2002 | US6403645 Antidepressant effect of norepinephrine uptake 2 inhibitors and combined medications including them |
| 06/11/2002 | US6403640 Method for treating chronic prostatitis or chronic pelvic pain syndrome |
| 06/11/2002 | US6403630 Administering a cyclooxygenase-2 (cox-2) inhibitor alone or in combination with herceptin? antibody; used to treat breast cancer |
| 06/11/2002 | US6403629 Heterocyclic compounds for therapeutic use |
| 06/11/2002 | US6403618 Administering picolinic acid derivatives to chelate with zinc and iron in proteins; antiangiogenic and antineoplastic agent |
| 06/11/2002 | US6403612 Urea containing compounds inhibit the aggregation of blood platelets; nontoxic |
| 06/11/2002 | US6403609 Topical-use lubricant that gels when administered to the eye |
| 06/11/2002 | US6403597 Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
| 06/11/2002 | US6403589 Nucleoside transport inhibitor |
| 06/11/2002 | US6403571 Administering anticoagulant and anticholesterol agent |
| 06/11/2002 | US6403565 Enhances dna repair and prevents consequences of mutagenic radiation even when administered after damage or exposure to radiation has already occurred; deoxyribonucleosides: deoxycytidine, deoxyadenosine, deoxyguanosine, and thymidine. |
| 06/11/2002 | US6403563 Antineoplastic topoisomerase i inhibitor |
| 06/11/2002 | US6403552 Ob receptor and methods for the diagnosis and treatment of body weight disorders |
| 06/11/2002 | US6403318 Fatty acid synthase mRNA binding protein |
| 06/11/2002 | US6403123 Topical application of anthralin that results in minimal or no staining of skin or clothing; applying a wax formulation over the involved area |
| 06/11/2002 | US6403117 Archaesomes, archaeosomes containing coenzyme Q10 and other types of liposomes containing coenzyme Q10 adjuvants and as delivery vehicles |
| 06/11/2002 | US6403116 Dimethyl sulfone, citric acid, and at least one polysorbate; dietary supplement; stable dispersions in aqueous medium for oral administration |
| 06/11/2002 | US6403089 Inhibitors of fgl2; bacterial and viral infections, allograft and xenograft rejection, glomerulonephritis, cancer, gastrointestinal diseases and fetal loss; monoclonal and polyclonal antibodies which bind to fgl2 and prevent fibrin |
| 06/11/2002 | US6403086 Administering extracts of morinda citrifolia, red wine, prune, blueberry, pomegranate, apple and an enzyme mixture |
| 06/11/2002 | US6403080 Methods of modulating an immune response to antigen, and cells for use in the method |
| 06/11/2002 | US6403063 Applying polyurea; curing |
| 06/11/2002 | CA2124218C Cytotoxic drug therapy |
| 06/11/2002 | CA2082390C Dna encoding human 5-ht1d receptors and uses thereof |
| 06/07/2002 | CA2360127A1 Method for treating chronic obstructive pulmonary disease |
| 06/06/2002 | WO2002045431A2 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | WO2002044736A2 Diagnosis and treatment of epidermal or skin diseases |
| 06/06/2002 | WO2002044734A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | WO2002044718A2 S.aureus protein staau r2, gene encoding it and uses thereof |
| 06/06/2002 | WO2002044418A2 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044417A2 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044396A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | WO2002044366A2 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | WO2002044364A2 Polypeptides involved in immune response |
| 06/06/2002 | WO2002044347A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it |
| 06/06/2002 | WO2002044342A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 06/06/2002 | WO2002044321A2 Rna interference mediating small rna molecules |
| 06/06/2002 | WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | WO2002044209A2 Cytonkine receptor zcytor19 |
| 06/06/2002 | WO2002044168A2 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | WO2002044159A2 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence |
| 06/06/2002 | WO2002044156A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors |
| 06/06/2002 | WO2002044113A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 06/06/2002 | WO2002043807A2 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drug or a statin, for the treatment of sexual dysfunction |
| 06/06/2002 | WO2002043785A2 Intraocular implants for preventing transplant rejection in the eye |
| 06/06/2002 | WO2002043765A2 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
| 06/06/2002 | WO2002043764A1 Behavior chemotherapy |
| 06/06/2002 | WO2002043763A2 Combination of gaba agonists and aldose reductase inhibitors |
| 06/06/2002 | WO2002043762A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | WO2002043758A2 Uses of mammalian genes and related reagents |
| 06/06/2002 | WO2002043742A1 Cyclodextrins and reversal of atherosclerosis |
| 06/06/2002 | WO2002043721A1 Treatment of statin side effects |
| 06/06/2002 | WO2002043719A2 Composition and method for treating snoring |